Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results.
about
The role of peptides in bone healing and regeneration: a systematic reviewProspective analysis of a new bone graft in lumbar interbody fusion: results of a 2- year prospective clinical and radiological studyBiograft-HT as a bone graft material in the treatment of periodontal vertical defects and its clinical and radiological evaluation: Clinical study.Treatment of plaque-induced gingivitis, chronic periodontitis, and other clinical conditions.Differences in osteoblast miRNA induced by cell binding domain of collagen and silicate-based synthetic bone.A systematic review of graft materials and biological agents for periodontal intraosseous defects.The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review.Clinical and biochemical comparison of guided tissue regeneration versus guided tissue regeneration plus low-level laser therapy in the treatment of class II furcation defects: A clinical study.Usage of Bone Replacement Grafts in Periodontics and Oral Implantology and Their Current Levels of Clinical Evidence - A Systematic Assessment.Which reconstructive procedures are effective for treating the periodontal intraosseous defect?Effects of P-15 Peptide Coated Hydroxyapatite on Tibial Defect Repair In Vivo in Normal and Osteoporotic RatsPeriodontal regeneration.Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with synthetic cell binding peptide sequencesP-15 small peptide bone graft substitute in the treatment of non-unions and delayed union. A pilot clinical trial.Clinical and radiographic evaluation of human periodontal osseous defect (mandibular grade II furcation) treated with PepGen P-15 and a bioresorbable membrane (Atrisorb)Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration.Early effects of p-15 on human bone marrow stem cells.Calcium orthophosphates in dentistry.Regenerative periodontal therapy: 30 years of lessons learned and unlearned.P-15 cell-binding domain derived from collagen: analysis of MG63 osteoblastic-cell response by means of a microarray technology.Evaluation of anorganic bovine-derived hydroxyapatite matrix/cell binding peptide as a bone graft material in the treatment of human periodontal infrabony defects: A clinico-radiographic study.Effect and timing of non-surgical treatment prior to periodontal regeneration: a systematic review.Short Anabolic Peptides for Bone Growth.Evaluation of effectiveness of hyaluronic acid in combination with bioresorbable membrane (poly lactic acid-poly glycolic acid) for the treatment of infrabony defects in humans: A clinical and radiographic study.In vivo evaluation of biofunctionalized implant surfaces with a synthetic peptide (P-15) and its impact on osseointegration. A preclinical animal study.The putative collagen-binding peptide P-15 promotes fibroblast attachment to root shavings but not hydroxyapatite.Fusion peptide P15-CSP shows antibiofilm activity and pro-osteogenic activity when deposited as a coating on hydrophilic but not hydrophobic surfaces.Evaluation of ABM/P-15 versus autogenous bone in an ovine lumbar interbody fusion modelClinical evaluation of a biphasic calcium phosphate grafting material in the treatment of human periodontal intrabony defectsInterdisciplinary management of an isolated intrabony defect.The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfacesOsteopromotion with synthetic oligopeptide-coated bovine bone mineral in vivo.The bone formation capabilities of the anorganic bone matrix-synthetic cell-binding peptide 15 grafts in an animal periodontal model: a histologic and histomorphometric study in dogs.A mineralization-associated membrane protein plays a role in the biological functions of the peptide-coated bovine hydroxyapatite.Enhancement of osseointegration of implants placed into extraction sockets of healthy and periodontally diseased teeth by using graft material, an ePTFE membrane, or a combination.Treatment of intrabony defects with anorganic bone matrix/p-15 or guided tissue regeneration in patients with aggressive periodontitis.Clinical evaluation of the combination of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in particulate and hydrogel form as a bone replacement graft material in human periodontal osseous defects: 6-month reentry controllUse of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of class II furcation defects: a clinical and radiographic study in humans.Treatment of Class III furcation defects with expanded polytetrafluoroethylene membrane associated or not with anorganic bone matrix/synthetic cell-binding peptide: a histologic and histomorphometric study in dogs.Healing patterns of critical size bony defects in rat following bone graft.
P2860
Q28079160-2C386A68-C3A8-4D73-9DB7-88199475E1BDQ28649565-62FA92BE-7DF8-4226-B84A-E89E38AEE4FBQ33766632-5BBD605D-465A-4E41-BFB4-B5594A81D613Q34111244-01F24A79-4EAE-4C17-B907-83FD5AFFCCA9Q34655995-AC85C698-AEFF-426D-A5D6-51F3E0D136AEQ35145364-CA981F25-9B77-4B7E-BF8A-24571AB6C2CEQ35670368-E81B8A09-7996-45A2-8D13-A1CD3196E1D4Q35886545-E852FCE0-B90D-4D1D-BCE6-2CC9A8DFD996Q35983623-1B718FD0-A56F-4891-8141-E19407DDCDF2Q36011890-A78D70BA-3BB2-4F15-813B-781A3514E0AFQ36174144-43A0A2D6-8CB2-4EB9-92F0-1FD8F2038D86Q36261011-F6E34985-DA21-47DA-B78F-56DE6AA6899FQ36399350-6363BBB3-DF35-4F7B-A8F7-7181C64B5B34Q36495738-2B97EFA0-9B56-4272-A596-267F1EB8B366Q36663829-BB1370D5-89CC-4921-920A-D93122025D68Q37251217-59C0D9CC-5A8D-4C9C-93E5-F0E17CC5ADA1Q37454612-C0BFA228-8C63-49C7-9557-B9F31957D0E0Q38087284-B0B679AF-4667-4E9B-AB35-D550FC544258Q38097943-FE3391DB-D845-4AE8-AF38-92B6F63484ECQ38343542-F5F3B381-9D74-46FC-BF80-984E23388339Q38440081-63CB8397-86A5-4BEA-8DE0-31C8051C1799Q38469004-EB194E1C-C67E-41A3-9A40-F44246EB89D4Q38864194-5CC92E65-8C6D-479D-B8CC-56DE13945F6FQ39077267-260EA7D9-F418-4D95-B6BE-CAFF69BFCD32Q40506144-93A6275A-E0AC-4966-BD3A-5F4C3F4A4174Q40647836-E9320FA2-0E96-49D9-A58A-EAC89A608A1EQ40813580-538413D7-60A7-4339-A31B-719EA9E42358Q41214721-7CA91392-EBC5-4BAD-A800-96B892BA4E95Q41844669-192A9786-1865-4670-940F-9FD38DDFDC3FQ41954322-7757217C-3CAB-479F-B96F-3B6504678B5AQ42151053-9B470313-8EEF-45F2-A5A2-202AD2A5E5A0Q42832404-308CD616-80AA-46F3-93AD-C569B5CDF157Q43109665-60985458-AA2F-4BC3-9154-5B5179B45A75Q46279287-D87C057C-53FF-40C8-83C9-85382F226A37Q46541101-A87E3CF8-30A9-4B5E-850A-3C9E36F1637AQ46612132-ABA312EA-5993-4CFC-8C9C-523554306FCAQ46864218-94E315DD-B6EA-40C4-B525-757C998CA4D5Q46871506-ABCAC0B8-60DD-4094-A9AC-169ACDA42F23Q46972189-40EC02CD-0033-4429-BCEB-FE946078E1F4Q47225975-F4C6B270-6EEB-4789-BA7E-08E1E551EC79
P2860
Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Multi-center clinical evaluati ...... eous defects. 6-month results.
@en
Multi-center clinical evaluati ...... -derived hydroxyapatite matrix
@nl
type
label
Multi-center clinical evaluati ...... eous defects. 6-month results.
@en
Multi-center clinical evaluati ...... -derived hydroxyapatite matrix
@nl
prefLabel
Multi-center clinical evaluati ...... eous defects. 6-month results.
@en
Multi-center clinical evaluati ...... -derived hydroxyapatite matrix
@nl
P2093
P2860
P1476
Multi-center clinical evaluati ...... eous defects. 6-month results.
@en
P2093
Aichelmann-Reidy ME
Krauser JT
P2860
P304
P356
10.1902/JOP.1998.69.6.655
P407
P577
1998-06-01T00:00:00Z